http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 20 Feb 2026 08:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the TD Cowen 46th Annual Healthcare Conference on Tuesday, March 3, 2026 at 2:30 PM ET in Boston, MA. </p><p> <b>Presentation Information <br /></b>A live webcast and replay of the session will be accessible at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2Fjl-DCKrYLwIpjVM7s3iRI5uTx4%3Fdomain%3Devent.summitcast.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevent.summitcast.com&amp;index=1&amp;md5=685fb25bde3ea339a83b0d766f9e17f6" shape="rect">https://event.summitcast.com</a> or on the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.adagiomedical.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.adagiomedical.com&amp;index=2&amp;md5=e188dce1819f4a415781819ff0b7aa03" shape="rect">https://investors.adagiomedical.com</a>. </p><p> <b>About Adagio Medical Holdings, Inc.</b> </p><p> Adagio is a medical device company focused on developing and commercializing http://www.streetinsider.com/Press+Releases/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html Fri, 20 Feb 2026 08:00:00 -0500 A.32635824 A.50100012 ADGM O.02054126 O.07579093 O.21503249 O.49933047 http://www.streetinsider.com/Press+Releases/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the TD Cowen 46th Annual Healthcare Conference on Tuesday, March 3, 2026 at 2:30 PM ET in Boston, MA. </p><p> <b>Presentation Information <br /></b>A live webcast and replay of the session will be accessible at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2Fjl-DCKrYLwIpjVM7s3iRI5uTx4%3Fdomain%3Devent.summitcast.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevent.summitcast.com&amp;index=1&amp;md5=685fb25bde3ea339a83b0d766f9e17f6" shape="rect">https://event.summitcast.com</a> or on the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.adagiomedical.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.adagiomedical.com&amp;index=2&amp;md5=e188dce1819f4a415781819ff0b7aa03" shape="rect">https://investors.adagiomedical.com</a>. </p><p> <b>About Adagio Medical Holdings, Inc.</b> </p><p> Adagio is a medical device company focused on developing and commercializing http://www.streetinsider.com/Press+Releases/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html Fri, 20 Feb 2026 08:00:00 -0500 A.32635824 A.50100012 ADGM O.02054126 O.07579093 O.21503249 O.49933047 http://www.streetinsider.com/Press+Releases/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the TD Cowen 46th Annual Healthcare Conference on Tuesday, March 3, 2026 at 2:30 PM ET in Boston, MA. </p><p> <b>Presentation Information <br /></b>A live webcast and replay of the session will be accessible at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2Fjl-DCKrYLwIpjVM7s3iRI5uTx4%3Fdomain%3Devent.summitcast.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevent.summitcast.com&amp;index=1&amp;md5=685fb25bde3ea339a83b0d766f9e17f6" shape="rect">https://event.summitcast.com</a> or on the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.adagiomedical.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.adagiomedical.com&amp;index=2&amp;md5=e188dce1819f4a415781819ff0b7aa03" shape="rect">https://investors.adagiomedical.com</a>. </p><p> <b>About Adagio Medical Holdings, Inc.</b> </p><p> Adagio is a medical device company focused on developing and commercializing http://www.streetinsider.com/Press+Releases/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html Fri, 20 Feb 2026 08:00:00 -0500 A.32635824 A.50100012 ADGM O.02054126 O.07579093 O.21503249 O.49933047 http://www.streetinsider.com/Press+Releases/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the TD Cowen 46th Annual Healthcare Conference on Tuesday, March 3, 2026 at 2:30 PM ET in Boston, MA. </p><p> <b>Presentation Information <br /></b>A live webcast and replay of the session will be accessible at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2Fjl-DCKrYLwIpjVM7s3iRI5uTx4%3Fdomain%3Devent.summitcast.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevent.summitcast.com&amp;index=1&amp;md5=685fb25bde3ea339a83b0d766f9e17f6" shape="rect">https://event.summitcast.com</a> or on the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.adagiomedical.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.adagiomedical.com&amp;index=2&amp;md5=e188dce1819f4a415781819ff0b7aa03" shape="rect">https://investors.adagiomedical.com</a>. </p><p> <b>About Adagio Medical Holdings, Inc.</b> </p><p> Adagio is a medical device company focused on developing and commercializing http://www.streetinsider.com/Press+Releases/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html Fri, 20 Feb 2026 08:00:00 -0500 A.32635824 A.50100012 ADGM O.02054126 O.07579093 O.21503249 O.49933047 http://www.streetinsider.com/Press+Releases/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the TD Cowen 46th Annual Healthcare Conference on Tuesday, March 3, 2026 at 2:30 PM ET in Boston, MA. </p><p> <b>Presentation Information <br /></b>A live webcast and replay of the session will be accessible at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2Fjl-DCKrYLwIpjVM7s3iRI5uTx4%3Fdomain%3Devent.summitcast.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevent.summitcast.com&amp;index=1&amp;md5=685fb25bde3ea339a83b0d766f9e17f6" shape="rect">https://event.summitcast.com</a> or on the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.adagiomedical.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.adagiomedical.com&amp;index=2&amp;md5=e188dce1819f4a415781819ff0b7aa03" shape="rect">https://investors.adagiomedical.com</a>. </p><p> <b>About Adagio Medical Holdings, Inc.</b> </p><p> Adagio is a medical device company focused on developing and commercializing http://www.streetinsider.com/Press+Releases/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html Fri, 20 Feb 2026 08:00:00 -0500 A.32635824 A.50100012 ADGM O.02054126 O.07579093 O.21503249 O.49933047 http://www.streetinsider.com/Press+Releases/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the TD Cowen 46th Annual Healthcare Conference on Tuesday, March 3, 2026 at 2:30 PM ET in Boston, MA. </p><p> <b>Presentation Information <br /></b>A live webcast and replay of the session will be accessible at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2Fjl-DCKrYLwIpjVM7s3iRI5uTx4%3Fdomain%3Devent.summitcast.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevent.summitcast.com&amp;index=1&amp;md5=685fb25bde3ea339a83b0d766f9e17f6" shape="rect">https://event.summitcast.com</a> or on the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.adagiomedical.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.adagiomedical.com&amp;index=2&amp;md5=e188dce1819f4a415781819ff0b7aa03" shape="rect">https://investors.adagiomedical.com</a>. </p><p> <b>About Adagio Medical Holdings, Inc.</b> </p><p> Adagio is a medical device company focused on developing and commercializing http://www.streetinsider.com/Press+Releases/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html Fri, 20 Feb 2026 08:00:00 -0500 A.32635824 A.50100012 ADGM O.02054126 O.07579093 O.21503249 O.49933047 http://www.streetinsider.com/Press+Releases/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the TD Cowen 46th Annual Healthcare Conference on Tuesday, March 3, 2026 at 2:30 PM ET in Boston, MA. </p><p> <b>Presentation Information <br /></b>A live webcast and replay of the session will be accessible at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2Fjl-DCKrYLwIpjVM7s3iRI5uTx4%3Fdomain%3Devent.summitcast.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevent.summitcast.com&amp;index=1&amp;md5=685fb25bde3ea339a83b0d766f9e17f6" shape="rect">https://event.summitcast.com</a> or on the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.adagiomedical.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.adagiomedical.com&amp;index=2&amp;md5=e188dce1819f4a415781819ff0b7aa03" shape="rect">https://investors.adagiomedical.com</a>. </p><p> <b>About Adagio Medical Holdings, Inc.</b> </p><p> Adagio is a medical device company focused on developing and commercializing http://www.streetinsider.com/Press+Releases/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html Fri, 20 Feb 2026 08:00:00 -0500 A.32635824 A.50100012 ADGM O.02054126 O.07579093 O.21503249 O.49933047 http://www.streetinsider.com/Business+Wire/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the TD Cowen 46th Annual Healthcare Conference on Tuesday, March 3, 2026 at 2:30 PM ET in Boston, MA. </p><p> <b>Presentation Information <br /></b>A live webcast and replay of the session will be accessible at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2Fjl-DCKrYLwIpjVM7s3iRI5uTx4%3Fdomain%3Devent.summitcast.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevent.summitcast.com&amp;index=1&amp;md5=685fb25bde3ea339a83b0d766f9e17f6" shape="rect">https://event.summitcast.com</a> or on the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.adagiomedical.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.adagiomedical.com&amp;index=2&amp;md5=e188dce1819f4a415781819ff0b7aa03" shape="rect">https://investors.adagiomedical.com</a>. </p><p> <b>About Adagio Medical Holdings, Inc.</b> </p><p> Adagio is a medical device company focused on developing and commercializing http://www.streetinsider.com/Business+Wire/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html Fri, 20 Feb 2026 08:00:00 -0500 A.32635824 A.50100012 ADGM O.02054126 O.07579093 O.21503249 O.49933047 http://www.streetinsider.com/Business+Wire/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the TD Cowen 46th Annual Healthcare Conference on Tuesday, March 3, 2026 at 2:30 PM ET in Boston, MA. </p><p> <b>Presentation Information <br /></b>A live webcast and replay of the session will be accessible at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2Fjl-DCKrYLwIpjVM7s3iRI5uTx4%3Fdomain%3Devent.summitcast.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevent.summitcast.com&amp;index=1&amp;md5=685fb25bde3ea339a83b0d766f9e17f6" shape="rect">https://event.summitcast.com</a> or on the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.adagiomedical.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.adagiomedical.com&amp;index=2&amp;md5=e188dce1819f4a415781819ff0b7aa03" shape="rect">https://investors.adagiomedical.com</a>. </p><p> <b>About Adagio Medical Holdings, Inc.</b> </p><p> Adagio is a medical device company focused on developing and commercializing http://www.streetinsider.com/Business+Wire/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html Fri, 20 Feb 2026 08:00:00 -0500 A.32635824 A.50100012 ADGM O.02054126 O.07579093 O.21503249 O.49933047 http://www.streetinsider.com/Business+Wire/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the TD Cowen 46th Annual Healthcare Conference on Tuesday, March 3, 2026 at 2:30 PM ET in Boston, MA. </p><p> <b>Presentation Information <br /></b>A live webcast and replay of the session will be accessible at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2Fjl-DCKrYLwIpjVM7s3iRI5uTx4%3Fdomain%3Devent.summitcast.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevent.summitcast.com&amp;index=1&amp;md5=685fb25bde3ea339a83b0d766f9e17f6" shape="rect">https://event.summitcast.com</a> or on the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.adagiomedical.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.adagiomedical.com&amp;index=2&amp;md5=e188dce1819f4a415781819ff0b7aa03" shape="rect">https://investors.adagiomedical.com</a>. </p><p> <b>About Adagio Medical Holdings, Inc.</b> </p><p> Adagio is a medical device company focused on developing and commercializing http://www.streetinsider.com/Business+Wire/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html Fri, 20 Feb 2026 08:00:00 -0500 A.32635824 A.50100012 ADGM O.02054126 O.07579093 O.21503249 O.49933047 http://www.streetinsider.com/Business+Wire/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the TD Cowen 46th Annual Healthcare Conference on Tuesday, March 3, 2026 at 2:30 PM ET in Boston, MA. </p><p> <b>Presentation Information <br /></b>A live webcast and replay of the session will be accessible at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2Fjl-DCKrYLwIpjVM7s3iRI5uTx4%3Fdomain%3Devent.summitcast.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevent.summitcast.com&amp;index=1&amp;md5=685fb25bde3ea339a83b0d766f9e17f6" shape="rect">https://event.summitcast.com</a> or on the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.adagiomedical.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.adagiomedical.com&amp;index=2&amp;md5=e188dce1819f4a415781819ff0b7aa03" shape="rect">https://investors.adagiomedical.com</a>. </p><p> <b>About Adagio Medical Holdings, Inc.</b> </p><p> Adagio is a medical device company focused on developing and commercializing http://www.streetinsider.com/Business+Wire/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html Fri, 20 Feb 2026 08:00:00 -0500 A.32635824 A.50100012 ADGM O.02054126 O.07579093 O.21503249 O.49933047 http://www.streetinsider.com/Business+Wire/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the TD Cowen 46th Annual Healthcare Conference on Tuesday, March 3, 2026 at 2:30 PM ET in Boston, MA. </p><p> <b>Presentation Information <br /></b>A live webcast and replay of the session will be accessible at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2Fjl-DCKrYLwIpjVM7s3iRI5uTx4%3Fdomain%3Devent.summitcast.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevent.summitcast.com&amp;index=1&amp;md5=685fb25bde3ea339a83b0d766f9e17f6" shape="rect">https://event.summitcast.com</a> or on the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.adagiomedical.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.adagiomedical.com&amp;index=2&amp;md5=e188dce1819f4a415781819ff0b7aa03" shape="rect">https://investors.adagiomedical.com</a>. </p><p> <b>About Adagio Medical Holdings, Inc.</b> </p><p> Adagio is a medical device company focused on developing and commercializing http://www.streetinsider.com/Business+Wire/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html Fri, 20 Feb 2026 08:00:00 -0500 A.32635824 A.50100012 ADGM O.02054126 O.07579093 O.21503249 O.49933047 http://www.streetinsider.com/Business+Wire/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the TD Cowen 46th Annual Healthcare Conference on Tuesday, March 3, 2026 at 2:30 PM ET in Boston, MA. </p><p> <b>Presentation Information <br /></b>A live webcast and replay of the session will be accessible at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2Fjl-DCKrYLwIpjVM7s3iRI5uTx4%3Fdomain%3Devent.summitcast.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevent.summitcast.com&amp;index=1&amp;md5=685fb25bde3ea339a83b0d766f9e17f6" shape="rect">https://event.summitcast.com</a> or on the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.adagiomedical.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.adagiomedical.com&amp;index=2&amp;md5=e188dce1819f4a415781819ff0b7aa03" shape="rect">https://investors.adagiomedical.com</a>. </p><p> <b>About Adagio Medical Holdings, Inc.</b> </p><p> Adagio is a medical device company focused on developing and commercializing http://www.streetinsider.com/Business+Wire/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html Fri, 20 Feb 2026 08:00:00 -0500 A.32635824 A.50100012 ADGM O.02054126 O.07579093 O.21503249 O.49933047 http://www.streetinsider.com/Business+Wire/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the TD Cowen 46th Annual Healthcare Conference on Tuesday, March 3, 2026 at 2:30 PM ET in Boston, MA. </p><p> <b>Presentation Information <br /></b>A live webcast and replay of the session will be accessible at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2Fjl-DCKrYLwIpjVM7s3iRI5uTx4%3Fdomain%3Devent.summitcast.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevent.summitcast.com&amp;index=1&amp;md5=685fb25bde3ea339a83b0d766f9e17f6" shape="rect">https://event.summitcast.com</a> or on the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.adagiomedical.com&amp;esheet=54429399&amp;newsitemid=20260220855414&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.adagiomedical.com&amp;index=2&amp;md5=e188dce1819f4a415781819ff0b7aa03" shape="rect">https://investors.adagiomedical.com</a>. </p><p> <b>About Adagio Medical Holdings, Inc.</b> </p><p> Adagio is a medical device company focused on developing and commercializing http://www.streetinsider.com/Business+Wire/Adagio+Medical+to+Participate+in+the+TD+Cowen+46th+Annual+Healthcare+Conference/26033163.html Fri, 20 Feb 2026 08:00:00 -0500 A.32635824 A.50100012 ADGM O.02054126 O.07579093 O.21503249 O.49933047 http://www.streetinsider.com/Press+Releases/Small+Cap+Growth+Virtual+Investor+Conference%3A+Presentations+Now+Available+for+On-Demand+Viewing/25958551.html <p><strong>Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com</strong></p><p>NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Small Cap Growth Virtual Investor Conference, held February 5^th are now available for on-demand viewing.</p> <p align="justify">Individual investors, institutional investors, advisors, and analysts are invited to attend.<br /><br /><a href="https://www.globenewswire.com/Tracker?data=inrEblmdOxf2dcqoddAPtVazC38dSUvX3CrkjL1P_0g2iYsoAcoow2INMg9Llwb4jCNZu-nE1pOei4CFwleh0iRtQs5ygCfSYXI03aypXS_sebtTI00JoH5v0bIskyXjgrd7HasndiUIGNL96sv5Sd_mql_tXeTfVnY1nbL6dTdcRJlfiIqRFo0ge9ZSZpF-m61xXpqfFnA2BR78Xg0_7ZG24q97Y3U2_rjMPC9eWO30HTgor5MSLy1ZuygGLhsNKeR_oHBD6M0SDxyXif1GtBKxbJ_T8njPJmVFfSpQOrdKaqZuX_6liOOvETxq3NLPg_nYZH2N6V6Cvb4syGlsvwDG4qupwkMrWKSURR2BDEc=" rel="nofollow" target="_blank">REGISTER AND VIEW PRESENTATIONS HERE</a></p> <p align="justify">The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section.</p> <p align="justify">Select companies are http://www.streetinsider.com/Press+Releases/Small+Cap+Growth+Virtual+Investor+Conference%3A+Presentations+Now+Available+for+On-Demand+Viewing/25958551.html Fri, 06 Feb 2026 08:35:00 -0500 ADGM COCH http://www.streetinsider.com/Press+Releases/Small+Cap+Growth+Virtual+Investor+Conference%3A+Presentations+Now+Available+for+On-Demand+Viewing/25958551.html <p><strong>Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com</strong></p><p>NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Small Cap Growth Virtual Investor Conference, held February 5^th are now available for on-demand viewing.</p> <p align="justify">Individual investors, institutional investors, advisors, and analysts are invited to attend.<br /><br /><a href="https://www.globenewswire.com/Tracker?data=inrEblmdOxf2dcqoddAPtVazC38dSUvX3CrkjL1P_0g2iYsoAcoow2INMg9Llwb4jCNZu-nE1pOei4CFwleh0iRtQs5ygCfSYXI03aypXS_sebtTI00JoH5v0bIskyXjgrd7HasndiUIGNL96sv5Sd_mql_tXeTfVnY1nbL6dTdcRJlfiIqRFo0ge9ZSZpF-m61xXpqfFnA2BR78Xg0_7ZG24q97Y3U2_rjMPC9eWO30HTgor5MSLy1ZuygGLhsNKeR_oHBD6M0SDxyXif1GtBKxbJ_T8njPJmVFfSpQOrdKaqZuX_6liOOvETxq3NLPg_nYZH2N6V6Cvb4syGlsvwDG4qupwkMrWKSURR2BDEc=" rel="nofollow" target="_blank">REGISTER AND VIEW PRESENTATIONS HERE</a></p> <p align="justify">The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section.</p> <p align="justify">Select companies are http://www.streetinsider.com/Press+Releases/Small+Cap+Growth+Virtual+Investor+Conference%3A+Presentations+Now+Available+for+On-Demand+Viewing/25958551.html Fri, 06 Feb 2026 08:35:00 -0500 ADGM COCH http://www.streetinsider.com/Globe+Newswire/Small+Cap+Growth+Virtual+Investor+Conference%3A+Presentations+Now+Available+for+On-Demand+Viewing/25958551.html <p><strong>Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com</strong></p><p>NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Small Cap Growth Virtual Investor Conference, held February 5^th are now available for on-demand viewing.</p> <p align="justify">Individual investors, institutional investors, advisors, and analysts are invited to attend.<br /><br /><a href="https://www.globenewswire.com/Tracker?data=inrEblmdOxf2dcqoddAPtVazC38dSUvX3CrkjL1P_0g2iYsoAcoow2INMg9Llwb4jCNZu-nE1pOei4CFwleh0iRtQs5ygCfSYXI03aypXS_sebtTI00JoH5v0bIskyXjgrd7HasndiUIGNL96sv5Sd_mql_tXeTfVnY1nbL6dTdcRJlfiIqRFo0ge9ZSZpF-m61xXpqfFnA2BR78Xg0_7ZG24q97Y3U2_rjMPC9eWO30HTgor5MSLy1ZuygGLhsNKeR_oHBD6M0SDxyXif1GtBKxbJ_T8njPJmVFfSpQOrdKaqZuX_6liOOvETxq3NLPg_nYZH2N6V6Cvb4syGlsvwDG4qupwkMrWKSURR2BDEc=" rel="nofollow" target="_blank">REGISTER AND VIEW PRESENTATIONS HERE</a></p> <p align="justify">The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section.</p> <p align="justify">Select companies are http://www.streetinsider.com/Globe+Newswire/Small+Cap+Growth+Virtual+Investor+Conference%3A+Presentations+Now+Available+for+On-Demand+Viewing/25958551.html Fri, 06 Feb 2026 08:35:00 -0500 ADGM COCH http://www.streetinsider.com/Globe+Newswire/Small+Cap+Growth+Virtual+Investor+Conference%3A+Presentations+Now+Available+for+On-Demand+Viewing/25958551.html <p><strong>Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com</strong></p><p>NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Small Cap Growth Virtual Investor Conference, held February 5^th are now available for on-demand viewing.</p> <p align="justify">Individual investors, institutional investors, advisors, and analysts are invited to attend.<br /><br /><a href="https://www.globenewswire.com/Tracker?data=inrEblmdOxf2dcqoddAPtVazC38dSUvX3CrkjL1P_0g2iYsoAcoow2INMg9Llwb4jCNZu-nE1pOei4CFwleh0iRtQs5ygCfSYXI03aypXS_sebtTI00JoH5v0bIskyXjgrd7HasndiUIGNL96sv5Sd_mql_tXeTfVnY1nbL6dTdcRJlfiIqRFo0ge9ZSZpF-m61xXpqfFnA2BR78Xg0_7ZG24q97Y3U2_rjMPC9eWO30HTgor5MSLy1ZuygGLhsNKeR_oHBD6M0SDxyXif1GtBKxbJ_T8njPJmVFfSpQOrdKaqZuX_6liOOvETxq3NLPg_nYZH2N6V6Cvb4syGlsvwDG4qupwkMrWKSURR2BDEc=" rel="nofollow" target="_blank">REGISTER AND VIEW PRESENTATIONS HERE</a></p> <p align="justify">The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section.</p> <p align="justify">Select companies are http://www.streetinsider.com/Globe+Newswire/Small+Cap+Growth+Virtual+Investor+Conference%3A+Presentations+Now+Available+for+On-Demand+Viewing/25958551.html Fri, 06 Feb 2026 08:35:00 -0500 ADGM COCH http://www.streetinsider.com/Corporate+News/Adagio+Medical+publishes+study+on+ultralow+temperature+ablation+for+heart+rhythm+disorder/25943440.html <p>Adagio Medical Holdings Inc (NASDAQ: ADGM) announced publication of results from a U.S. early feasibility study evaluating its ultralow temperature cardiac ablation technology for treating ventricular tachycardia. The study appeared in Circulation: Arrhythmia and Electrophysiology.</p><p>The prospective, multi-center study enrolled 20 patients with both ischemic and non-ischemic cardiomyopathy across four U.S. tertiary referral centers. The study was conducted under the FDA's Early Feasibility Study program to evaluate acute safety and performance of the company's ultralow temperature ablation in patients with drug-refractory scar-related ventricular tachycardia.</p><p>Results showed no device- or procedure-related major adverse events at seven and 30 days. Among 14 patients with http://www.streetinsider.com/Corporate+News/Adagio+Medical+publishes+study+on+ultralow+temperature+ablation+for+heart+rhythm+disorder/25943440.html Wed, 04 Feb 2026 08:04:24 -0500 ADGM http://www.streetinsider.com/Press+Releases/New+Adagio+Medical+Publication+Highlights+Consistent+Safety+and+Effectiveness+with+Ultralow+Temperature+Ablation+in+Broad+Range+of+Patients+with+Ventricular+Tachycardia/25943268.html <p class="bwalignc"> <b><i>Early Feasibility Outcomes in a Real-World Patient Cohort of Both Ischemic and Challenging Non-Ischemic Patients Published in Circulation: Arrhythmia and Electrophysiology</i></b> </p> <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the publication of results from the U.S. Early Feasibility Study (“EFS”) evaluating ultralow temperature cardiac ablation (“ULTC”) for the treatment of scar-related ventricular tachycardia (“VT”). The study was published in <i>Circulation: Arrythmia and Electrophysiology.</i> </p><p> The prospective, multi-center study was conducted under the U.S. Food and Drug Administration’s (“FDA’s”) http://www.streetinsider.com/Press+Releases/New+Adagio+Medical+Publication+Highlights+Consistent+Safety+and+Effectiveness+with+Ultralow+Temperature+Ablation+in+Broad+Range+of+Patients+with+Ventricular+Tachycardia/25943268.html Wed, 04 Feb 2026 08:00:00 -0500 A.10745066 A.32635824 ADGM O.02054126 O.21503249 O.26228129 O.49933047 http://www.streetinsider.com/Press+Releases/New+Adagio+Medical+Publication+Highlights+Consistent+Safety+and+Effectiveness+with+Ultralow+Temperature+Ablation+in+Broad+Range+of+Patients+with+Ventricular+Tachycardia/25943268.html <p class="bwalignc"> <b><i>Early Feasibility Outcomes in a Real-World Patient Cohort of Both Ischemic and Challenging Non-Ischemic Patients Published in Circulation: Arrhythmia and Electrophysiology</i></b> </p> <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the publication of results from the U.S. Early Feasibility Study (“EFS”) evaluating ultralow temperature cardiac ablation (“ULTC”) for the treatment of scar-related ventricular tachycardia (“VT”). The study was published in <i>Circulation: Arrythmia and Electrophysiology.</i> </p><p> The prospective, multi-center study was conducted under the U.S. Food and Drug Administration’s (“FDA’s”) http://www.streetinsider.com/Press+Releases/New+Adagio+Medical+Publication+Highlights+Consistent+Safety+and+Effectiveness+with+Ultralow+Temperature+Ablation+in+Broad+Range+of+Patients+with+Ventricular+Tachycardia/25943268.html Wed, 04 Feb 2026 08:00:00 -0500 A.10745066 A.32635824 ADGM O.02054126 O.21503249 O.26228129 O.49933047 http://www.streetinsider.com/Press+Releases/New+Adagio+Medical+Publication+Highlights+Consistent+Safety+and+Effectiveness+with+Ultralow+Temperature+Ablation+in+Broad+Range+of+Patients+with+Ventricular+Tachycardia/25943268.html <p class="bwalignc"> <b><i>Early Feasibility Outcomes in a Real-World Patient Cohort of Both Ischemic and Challenging Non-Ischemic Patients Published in Circulation: Arrhythmia and Electrophysiology</i></b> </p> <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the publication of results from the U.S. Early Feasibility Study (“EFS”) evaluating ultralow temperature cardiac ablation (“ULTC”) for the treatment of scar-related ventricular tachycardia (“VT”). The study was published in <i>Circulation: Arrythmia and Electrophysiology.</i> </p><p> The prospective, multi-center study was conducted under the U.S. Food and Drug Administration’s (“FDA’s”) http://www.streetinsider.com/Press+Releases/New+Adagio+Medical+Publication+Highlights+Consistent+Safety+and+Effectiveness+with+Ultralow+Temperature+Ablation+in+Broad+Range+of+Patients+with+Ventricular+Tachycardia/25943268.html Wed, 04 Feb 2026 08:00:00 -0500 A.10745066 A.32635824 ADGM O.02054126 O.21503249 O.26228129 O.49933047 http://www.streetinsider.com/Press+Releases/New+Adagio+Medical+Publication+Highlights+Consistent+Safety+and+Effectiveness+with+Ultralow+Temperature+Ablation+in+Broad+Range+of+Patients+with+Ventricular+Tachycardia/25943268.html <p class="bwalignc"> <b><i>Early Feasibility Outcomes in a Real-World Patient Cohort of Both Ischemic and Challenging Non-Ischemic Patients Published in Circulation: Arrhythmia and Electrophysiology</i></b> </p> <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the publication of results from the U.S. Early Feasibility Study (“EFS”) evaluating ultralow temperature cardiac ablation (“ULTC”) for the treatment of scar-related ventricular tachycardia (“VT”). The study was published in <i>Circulation: Arrythmia and Electrophysiology.</i> </p><p> The prospective, multi-center study was conducted under the U.S. Food and Drug Administration’s (“FDA’s”) http://www.streetinsider.com/Press+Releases/New+Adagio+Medical+Publication+Highlights+Consistent+Safety+and+Effectiveness+with+Ultralow+Temperature+Ablation+in+Broad+Range+of+Patients+with+Ventricular+Tachycardia/25943268.html Wed, 04 Feb 2026 08:00:00 -0500 A.10745066 A.32635824 ADGM O.02054126 O.21503249 O.26228129 O.49933047 http://www.streetinsider.com/Press+Releases/New+Adagio+Medical+Publication+Highlights+Consistent+Safety+and+Effectiveness+with+Ultralow+Temperature+Ablation+in+Broad+Range+of+Patients+with+Ventricular+Tachycardia/25943268.html <p class="bwalignc"> <b><i>Early Feasibility Outcomes in a Real-World Patient Cohort of Both Ischemic and Challenging Non-Ischemic Patients Published in Circulation: Arrhythmia and Electrophysiology</i></b> </p> <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the publication of results from the U.S. Early Feasibility Study (“EFS”) evaluating ultralow temperature cardiac ablation (“ULTC”) for the treatment of scar-related ventricular tachycardia (“VT”). The study was published in <i>Circulation: Arrythmia and Electrophysiology.</i> </p><p> The prospective, multi-center study was conducted under the U.S. Food and Drug Administration’s (“FDA’s”) http://www.streetinsider.com/Press+Releases/New+Adagio+Medical+Publication+Highlights+Consistent+Safety+and+Effectiveness+with+Ultralow+Temperature+Ablation+in+Broad+Range+of+Patients+with+Ventricular+Tachycardia/25943268.html Wed, 04 Feb 2026 08:00:00 -0500 A.10745066 A.32635824 ADGM O.02054126 O.21503249 O.26228129 O.49933047 http://www.streetinsider.com/Press+Releases/New+Adagio+Medical+Publication+Highlights+Consistent+Safety+and+Effectiveness+with+Ultralow+Temperature+Ablation+in+Broad+Range+of+Patients+with+Ventricular+Tachycardia/25943268.html <p class="bwalignc"> <b><i>Early Feasibility Outcomes in a Real-World Patient Cohort of Both Ischemic and Challenging Non-Ischemic Patients Published in Circulation: Arrhythmia and Electrophysiology</i></b> </p> <p> LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the publication of results from the U.S. Early Feasibility Study (“EFS”) evaluating ultralow temperature cardiac ablation (“ULTC”) for the treatment of scar-related ventricular tachycardia (“VT”). The study was published in <i>Circulation: Arrythmia and Electrophysiology.</i> </p><p> The prospective, multi-center study was conducted under the U.S. Food and Drug Administration’s (“FDA’s”) http://www.streetinsider.com/Press+Releases/New+Adagio+Medical+Publication+Highlights+Consistent+Safety+and+Effectiveness+with+Ultralow+Temperature+Ablation+in+Broad+Range+of+Patients+with+Ventricular+Tachycardia/25943268.html Wed, 04 Feb 2026 08:00:00 -0500 A.10745066 A.32635824 ADGM O.02054126 O.21503249 O.26228129 O.49933047